| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 |
|---|---|---|---|---|---|---|---|---|
REVENUES: | ||||||||
Product revenue | ||||||||
29,206 | 16,842 | 15,617 | - | - | - | - | - | - |
Product revenue | ||||||||
- | - | - | 10,518 | 7,050 | 5,839 | 3,023 | 1,118 | - |
License revenue | ||||||||
142 | 142 | 142 | - | 127 | 75 | 44 | 0 | - |
License and other revenue | ||||||||
- | - | - | 142 | - | - | - | - | - |
Other revenue | ||||||||
- | - | 7,000 | 0 | - | - | - | - | - |
Total Revenues | ||||||||
29,349 | 16,985 | 22,760 | 10,661 | 7,177 | 5,915 | 3,067 | 1,118 | 761 |
OPERATING EXPENSES | ||||||||
Cost of product revenue (exclusive of amortization expense shown below) | ||||||||
39,504 | 42,194 | 29,164 | - | - | - | - | - | - |
Cost of product revenue (exclusive of amortization expense shown below) | ||||||||
- | - | - | 6,360 | 4,311 | 3,742 | 2,023 | 669 | 207 |
Gross profit | ||||||||
- | - | - | - | - | - | - | - | 553 |
Research and development | ||||||||
2,343 | 3,926 | 5,570 | 7,688 | 7,015 | 9,517 | 9,303 | 3,469 | 646 |
Loss on sale of inventory | ||||||||
- | - | - | - | - | - | - | - | 1,934 |
Plasma center operating expenses | ||||||||
2,169 | 7,805 | 6,503 | 5,447 | 4,618 | 3,850 | 2,418 | 1,746 | 1,163 |
Asset impairment charge | ||||||||
- | - | 845 | 0 | - | - | - | - | - |
Amortization of intangible assets | ||||||||
844 | 844 | 1,234 | 0 | - | - | - | - | - |
Selling, general and administrative | ||||||||
25,910 | 22,502 | 18,752 | 8,494 | 6,745 | 4,823 | 4,365 | 3,142 | 1,431 |
TOTAL OPERATING EXPENSES | ||||||||
70,773 | 77,274 | 62,070 | 27,991 | 22,691 | 21,934 | 18,110 | 9,027 | 5,176 |
LOSS FROM OPERATIONS | ||||||||
-41,424 | -60,288 | -39,309 | -17,330 | -15,513 | -16,018 | -15,042 | -7,909 | -4,622 |
OTHER INCOME (EXPENSE): | ||||||||
Interest and other income | ||||||||
800 | 195 | 57 | 50 | 37 | 14 | 7 | 20 | - |
Interest income | ||||||||
- | - | - | - | - | - | - | - | 1 |
Interest expense | ||||||||
8,993 | 5,522 | 3,285 | 2,239 | 1,842 | 1,286 | 618 | 30 | 1,602 |
Change in fair value of stock warrants | ||||||||
- | - | - | - | 67 | -74 | 43 | 0 | - |
Loss on extinguishment of debt | ||||||||
-9,962 | 0 | -1,210 | 0 | -719 | 0 | - | - | - |
Gain on transfer of plasma center assets | ||||||||
11,527 | 0 | - | - | - | - | - | - | - |
Other expense | ||||||||
- | - | - | - | 0 | - | 82 | 0 | - |
Other expense | ||||||||
-227 | -127 | -10 | 4 | - | - | - | - | - |
Other (expense) income, net | ||||||||
-6,854 | -5,454 | -4,448 | -2,184 | -2,456 | -1,346 | -484 | -9 | - |
LOSS BEFORE INCOME TAXES | ||||||||
- | - | - | - | - | -17,364 | -15,527 | -7,918 | -6,224 |
State income tax benefit | ||||||||
- | - | - | - | - | -551 | 0 | -617 | -320 |
NET LOSS | ||||||||
-48,279 | -65,743 | -43,758 | -19,515 | -17,969 | -16,813 | -15,527 | -7,301 | -5,903 |
BASIC AND DILUTED LOSS PER COMMON SHARE | ||||||||
-0.89 | -1.45 | -1.91 | -1.61 | -1.73 | -1.81 | -2.38 | -1.39 | -16.72 |
WEIGHTED AVERAGE SHARES OUTSTANDING, Basic and Diluted | ||||||||
54,348 | 45,188 | 22,896 | 12,153 | 10,412 | 9,291 | 6,531 | 5,265 | 353 |